Women's health Clinical Trials in Seattle, WA
As of September 2026, 53 paid clinical trials are recruiting for Women's health in Seattle, Washington. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
53 clinical trials for Women's health
·Clear filters·A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Contraceptive Efficacy Study of Ovaprene
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A Study of NX-1607 in Adults With Advanced Malignancies
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
Clinical Pre-screening Protocol for Ovarian Cancer
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Top Research Study Locations in Seattle
Researchers run research studies in Seattle, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Seattle Children's Hospital | Diffuse Intrinsic Pontine Glioma, Cystic Fibrosis, High Grade Glioma | 185 |
| University of Washington | Amyotrophic Lateral Sclerosis, Spinal Cord Injuries, Breast Cancer | 183 |
| Fred Hutchinson Cancer Center | Breast Cancer, Acute Myeloid Leukemia, Colorectal Cancer | 141 |
| Fred Hutch/University of Washington Cancer Consortium | Acute Myeloid Leukemia, Hematopoietic and Lymphatic System Neoplasm, Stage IVB Prostate Cancer AJCC v8 | 104 |
| Swedish Medical Center-First Hill | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm | 65 |
| University of Washington Medical Center | Cystic Fibrosis, Heart Diseases, Heart Transplant | 50 |
| University of Washington Medical Center - Montlake | Prostate Adenocarcinoma, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 39 |
| Fred Hutchinson Cancer Research Center | Chronic Lymphocytic Leukemia, Advanced Solid Tumor, Chronic Graft-versus-host-disease | 36 |
| Swedish Cancer Institute | Breast Cancer, Endometrial Cancer, Chronic Lymphocytic Leukemia | 34 |
| Swedish Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 32 |
| Virginia Mason Medical Center | Breast Cancer, Colorectal Cancer, Hearing Loss, Unilateral | 31 |
| Swedish Medical Center-Ballard Campus | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Ovarian Carcinoma | 30 |
| Swedish Medical Center-Cherry Hill | Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Ovarian Carcinoma | 29 |
| Harborview Medical Center | Spinal Cord Injuries, Urothelial Carcinoma, Abdominal Aortic Aneurysms | 20 |
| VA Puget Sound Health Care System Seattle Division, Seattle, WA | Obesity, Adult Growth Hormone Deficiency, Advanced Urothelial Carcinoma | 20 |
| Seattle Children's | Suicidal Ideation, Acute Kidney Injury, Becker Muscular Dystrophy | 16 |
| FHCC at Northwest Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 14 |
| Fred Hutch Cancer Center | Colorectal Cancer, Advanced Adenocarcinoma, Astrocytoma, Grade IV | 11 |
| GSK Investigational Site | HIV Infections, Non-alcoholic Fatty Liver Disease, Gastrointestinal Neoplasms | 11 |
| VA Puget Sound Health Care System | Parkinson's Disease, Barrett's Esophagus, Carcinoma, Non-Small-Cell Lung | 11 |
| Benaroya Research Institute | Type 1 Diabetes Mellitus, Acute Pancreatitis, T1D | 9 |
| Seattle Children's Research Institute | ADA SCID, Adolescent Behavior, Brain Concussion | 8 |
| Seattle Clinical Research Center | Obesity, Overweight, Acute Migraine | 7 |
| Seattle Cancer Care Alliance | Acute Myeloid Leukemia, Breast Cancer, Chronic Myelomonocytic Leukemia | 6 |
| University of Washington - Harborview Medical Center | Aneurysm, Intracranial, Brain Aneurysm, CPAP | 6 |
Active & Upcoming Studies in Seattle (2026)
Recruiting trials in Seattle grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (486 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · Phase 2 · Fred Hutchinson Cancer Center
Neurology & pain (62 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Morphine or Ketamine for Analgesia · Phase 3 · Columbia University
Diabetes & metabolic (59 active studies)
- METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) · Phase 2 · University of Washington
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS) · Phase 3 · Eli Lilly and Company
Cardiovascular (51 active studies)
- A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF) · Phase 2 · Edgewise Therapeutics, Inc.
- Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) · Phase 2 · Stanford University
Mental health & behavior (28 active studies)
- VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia · University of Washington
- A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01 · Fred Hutchinson Cancer Center
Pediatric (28 active studies)
- Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). · Phase 2 · BrainChild Bio, Inc
- Mobile Technology to Reduce Teen Substance Misuse · Evidence-Based Practice Institute, Seattle, WA
HIV / STI (15 active studies)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
- A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (12 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age · Phase 2 · ModernaTX, Inc.
Eye & vision (2 active studies)
- Disulfiram for Treatment of Retinal Degeneration · Phase 1, Phase 2 · University of Washington
- The Myelin Disorders Biorepository Project · Children's Hospital of Philadelphia
Common conditions studied in Seattle
- Acute Myeloid Leukemia (34 active studies)
- Breast Cancer (20 active studies)
- Colorectal Cancer (20 active studies)
- Ovarian Cancer (16 active studies)
- Prostate Cancer (14 active studies)
- Chronic Lymphocytic Leukemia (13 active studies)
Leading research sponsors in Seattle
- University of Washington
- Fred Hutchinson Cancer Center
- National Cancer Institute (NCI)
- Seattle Children's Hospital
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Seattle?
There are approximately 1,286 recruiting clinical trials in Seattle, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Seattle pay participants?
Most recruiting trials in Seattle compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Seattle?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Seattle?
The most common conditions under active study in Seattle include Acute Myeloid Leukemia (34), Breast Cancer (20), Colorectal Cancer (20), Ovarian Cancer (16), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Seattle?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Seattle on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Seattle?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Seattle?
Recruiting research sites in Seattle include Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Seattle right now?
The largest active categories in Seattle are Cancer & tumors (486), Neurology & pain (62), Diabetes & metabolic (59). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.